GET AHEAD WITH CLEARER SKIN
AND LESS ITCH

DUPIXENT was studied in a 16-week clinical trial in 251 patients ages 12-17 years with moderate-to-
severe eczema not adequately controlled with topical prescription treatments.

In a clinical trial at 16 weeks in teens (aged 12-17 years) taking DUPIXENT* when used alone compared to teens not taking DUPIXENT:

 

Clearer skin 12XSAW CLEAR or
Almost clear SKIN
VS
24% vs 2% not taking DUPIXENT (placebo)
nOTICEABLY LESS ITCH ~7XEXPERIENCED ITCH
RELIEF
VS
37% vs 5% not taking DUPIXENT (placebo)

Proven Results

≥75%SKIN IMPROVEMENT IN
NEARLY HALF OF TEENS
VS
42% vs 8% not taking DUPIXENT (placebo)
SOME
SAW
≥90%Skin
IMPROVEMENT
VS
23% vs 2% not taking DUPIXENT (placebo)

Your healthcare provider will tell you how much DUPIXENT to inject and how often.

*Patients who weighed 132 lb or more received DUPIXENT 300 mg every 2 weeks after an initial loading dose of 600 mg (two 300-mg injections), and patients who
weighed less than 132 lb received DUPIXENT 200 mg every 2 weeks after an initial loading dose of 400 mg (two 200-mg injections)

The most common side effects in patients with eczema include:

  • Injection site reactions
  • Eye and eyelid inflammation, including redness, swelling,
    and itching, sometimes with blurred vision
  • Cold sores in your mouth or on your lips
  • High count of a certain white blood cell (eosinophilia)

Long-term safety results for teens continuing on DUPIXENT in the pediatric extension study
through 1 year
were consistent with the adult clinical trials.

View the possible side effects of DUPIXENT in patients with moderate-to-severe eczema (atopic dermatitis).

What You Should Know About the Patients in This Study:

46%
Had moderate
atopic dermatitis
54%
Had severe
atopic dermatitis
~15 years
Average age
57%
Average body surface area involvement
92%
Had at least 1 other allergic condition

SEE BEFORE AND AFTER RESULTS IN TEENS

Use the slider to view these before and after results of an actual 12-year-old patient after 16 weeks of treatment with DUPIXENT in a clinical trial. This patient did not meet clinical trial criteria for clear or almost clear skin at 16 weeks. Individual results may vary.

Click and drag
to see results

We were a little skeptical at first.
Then, we noticed her skin clearing and
improving over time. It was such a relief
to find something that works for her.

- Yetunde, caregiver of Ore (pictured right),
teen patient taking DUPIXENT
Individual results may vary.

HAVE A productive CONVERSATION
WITH YOUR DOCTOR

Our goal is for you or your loved one to get the most out of your visit to the doctor. Fill out our personalized discussion guide to help yourself have a productive conversation during your next visit.

GET THE SPANISH CAREGIVER DISCUSSION GUIDE

Caregivers

Find more information, tips, and
guidance
on the Caregiver
Resources page.

Go to the DUPIXENT Dosing page to learn more about dosing and administration information.

Go to the How DUPIXENT Is Taken page to learn more about dosing and administration information.

Get email updates

Sign up to get more information, including helpful tools and resources, in your inbox with DUPIXENT MyWay® email updates.

GET STARTED